204 related articles for article (PubMed ID: 23329838)
1. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells.
Rasheed SAK; Teo CR; Beillard EJ; Voorhoeve PM; Casey PJ
J Biol Chem; 2013 Mar; 288(11):7986-7995. PubMed ID: 23329838
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
3. Gα-13 induces C
Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ
J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124
[TBL] [Abstract][Full Text] [Related]
4. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
5. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
[TBL] [Abstract][Full Text] [Related]
6. c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells.
Udayappan UK; Casey PJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28394299
[No Abstract] [Full Text] [Related]
7. A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.
Kelly P; Stemmle LN; Madden JF; Fields TA; Daaka Y; Casey PJ
J Biol Chem; 2006 Sep; 281(36):26483-90. PubMed ID: 16787920
[TBL] [Abstract][Full Text] [Related]
8. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
9. GNA13 as a prognostic factor and mediator of gastric cancer progression.
Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.
Wei JJ; Wu X; Peng Y; Shi G; Basturk O; Yang X; Daniels G; Osman I; Ouyang J; Hernando E; Pellicer A; Rhim JS; Melamed J; Lee P
Clin Cancer Res; 2011 Mar; 17(6):1297-305. PubMed ID: 21138859
[TBL] [Abstract][Full Text] [Related]
12. GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.
Rasheed SAK; Leong HS; Lakshmanan M; Raju A; Dadlani D; Chong FT; Shannon NB; Rajarethinam R; Skanthakumar T; Tan EY; Hwang JSG; Lim KH; Tan DS; Ceppi P; Wang M; Tergaonkar V; Casey PJ; Iyer NG
Oncogene; 2018 Mar; 37(10):1340-1353. PubMed ID: 29255247
[TBL] [Abstract][Full Text] [Related]
13. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells.
Zhang Z; Tan X; Luo J; Cui B; Lei S; Si Z; Shen L; Yao H
Cancer Med; 2018 Nov; 7(11):5611-5620. PubMed ID: 30267476
[TBL] [Abstract][Full Text] [Related]
14. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
[TBL] [Abstract][Full Text] [Related]
15. miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.
Lewis H; Lance R; Troyer D; Beydoun H; Hadley M; Orians J; Benzine T; Madric K; Semmes OJ; Drake R; Esquela-Kerscher A
Cell Cycle; 2014; 13(2):227-39. PubMed ID: 24200968
[TBL] [Abstract][Full Text] [Related]
16. High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma.
Xu Y; Rong J; Duan S; Chen C; Li Y; Peng B; Yi B; Zheng Z; Gao Y; Wang K; Yun M; Weng H; Zhang J; Ye S
Sci Rep; 2016 Nov; 6():35948. PubMed ID: 27883022
[TBL] [Abstract][Full Text] [Related]
17. miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene.
Muhammad S; Tang Q; Wei L; Zhang Q; Wang G; Muhammad BU; Kaur K; Kamchedalova T; Gang Z; Jiang Z; Liu Z; Wang X
Exp Ther Med; 2019 Jan; 17(1):260-272. PubMed ID: 30651791
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.
Scarlett KA; White EZ; Coke CJ; Carter JR; Bryant LK; Hinton CV
Mol Cancer Res; 2018 Apr; 16(4):728-739. PubMed ID: 29330286
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
[TBL] [Abstract][Full Text] [Related]
20. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
Uygur B; Wu WS
Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]